-
How a psychological therapy changed my life
The Brain Tumour Charity are excited to announce that we will be funding a study exploring whether a psychological therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.
-
Harnessing AI to help diagnose brain tumours
With funding from The Brain Tumour Charity, researchers in Toronto, Canada are using the power of artificial intelligence (AI) to improve brain tumour diagnosis
-
Helping someone with speech and communication difficulties
We teamed up with Julie Emerson, neuro-oncology specific Speech and Language Therapist at The Christie NHS Foundation Trust, to share some strategies that may help if your loved one is affected by speech and communication problems.
-
Our benefits clinic is transforming
From 11 July we’ll be expanding our benefits advice service to offer appointments two days every week, allowing us to support twice as many people.
-
Top tips to help with speech and communication difficulties
We teamed up with Neuro-oncology specific Speech and Language Therapist at The Christie NHS Foundation Trust, Julie Emerson, to share some tips and techniques to help with speech problems and communication difficulties.
-
Patients struggling to access cannabis-based medicine via prescription, report finds
A report published today into the use of medicinal cannabis for problems such as nausea caused by chemotherapy says patients have had their expectations raised unfairly by a change in the law last year
-
Top tips from top fundraisers
If you want to get off the fundraising start line, boost your total higher, or push yourself to raise even more for a cure then our dedicated community are here to help.
-
The launch of Celebrating You 2020
Celebrating You, The Brain Tumour Charity’s community awards event, returns in May 2020 and nominations are now open!
-
Announcing our funding of a major new role at The University of Manchester
We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.
-
Reporting from the American Society of Clinical Oncology
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference
-
Driving change in Scotland
Our Policy & Public Affairs Officer, Helena Brown, reports from Scotland
-
Predicting the risk of meningioma recurrence
Our funded research has created a tool to help clinicians predict meningioma recurrence
-
Announcing our research partnership investment with CRUK
Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.
-
The response to our joint cancer charity letter to the Department of Health
In February, we co-signed a joint letter with other cancer charities to the Secretary of State for Health and Social Care which outlined concerns regarding cancer research in the UK post Brexit
-
Three things from NHS England’s interim workforce plan
Earlier this month, NHS England released their ‘Interim NHS People’s Plan’ detailing what measures will be implemented in and ahead of their full workforce proposal
-
Announcing our new £3.7m global research investment
Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease
-
Top exam tips
Most people find exams stressful and it’s safe to say that living with a brain tumour doesn’t make them any easier! Kaleb Ells, a member of our young adults community, has shared some of his top tips for getting through exam season.
-
Tocagen’s ‘breakthrough’ gene therapy trial will continue
After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue
-
Data access vital for NHS digital revolution
The Health Secretary, Matt Hancock, has spoken today of his frustration at slow progress towards embracing digital technology in the NHS.
-
Launching The Twilight Walk 2019
Side by side, stride by stride, let’s pick up the pace of progress
-
Analysis shows Deputax-M is unsuccessful
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
-
Nivolumab fails to meet its target
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
-
Telling your loved ones about your brain tumour diagnosis
Chartered Clinical Psychologist, Dr Nick Mooney, offers advice on how best to start talking with your family and friends about brain tumours.
-
Redefining medulloblastoma
New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma